| ALNY | Alnylam Pharmaceuticals Inc | 10.74% |
| LH | Labcorp Holdings Inc | 7.07% |
| DGX | Quest Diagnostics Inc | 6.72% |
| BNTX | BioNTech SE ADR | 5.29% |
| BIO | Bio-Rad Laboratories Inc Class A | 4.75% |
| PCVX | Vaxcyte Inc Ordinary Shares | 4.53% |
| ZLAB | Zai Lab Ltd ADR Repr 1 Shs | 4.27% |
| BCRX | BioCryst Pharmaceuticals Inc | 4.08% |
| QDEL | QuidelOrtho Corp | 4.04% |
| IMCR | Immunocore Holdings PLC ADR | 3.42% |
The index tracks the performance of U.S.-listed equity securities or depositary receipts of companies that (i) perform research, development, and commercialization of treatments or vaccines for infectious diseases or (ii) engage in the research, development, manufacturing, and provision of biological tests for patients. The fund invests at least 80% of its total assets in the component securities of the index. The fund is non-diversified.
ETFMG Treatments, Testing and Advancements ETF · Issued by Amplify
No recent news for GERM. The ingest cron pulls every 15 minutes during market hours.